CURB-65 score

The CURB-65 score is a clinical prediction tool used to assess the severity of community-acquired pneumonia (CAP) in adults and guide decisions on treatment setting (outpatient, inpatient, or ICU). Developed in 2003 by Lim et al., it stratifies patients based on mortality risk using five simple criteria. The acronym stands for Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 years. CURB-65 is widely used in emergency departments, primary care, and hospital settings due to its simplicity and validated prognostic accuracy.

Purpose

• Clinical: Determines CAP severity to guide hospitalization or ICU admission decisions.
• Prognostic: Estimates 30-day mortality risk to inform patient management and counseling.
• Resource Allocation: Helps optimize healthcare resources by identifying low-risk patients suitable for outpatient care.
• Research: Standardizes CAP severity in clinical studies and trials.

Components of CURB-65 Score

The CURB-65 score (range: 0–5) assigns one point for each of the following criteria present at presentation:

1. Confusion: New onset of altered mental status (e.g., disorientation to time, place, or person), often assessed using the Abbreviated Mental Test Score (<8) or clinical judgment.
2. Urea >7 mmol/L (>19 mg/dL): Elevated blood urea nitrogen, indicating renal impairment or dehydration.
3. Respiratory Rate ≥30 breaths/min: Reflects respiratory distress.
4. Blood Pressure: Systolic BP <90 mmHg or diastolic BP ≤60 mmHg, indicating hemodynamic instability.
5. Age ≥65 years: Older age as a risk factor for poor outcomes.

Scoring and Interpretation

• 0–1: Low risk (mortality <3%), suitable for outpatient treatment.
• 2: Moderate risk (mortality ~9%), consider hospital admission.
• 3–5: High risk (mortality 15–40%), consider ICU admission, especially for scores of 4–5.

Clinical Application

1. Triage: Guides decisions on whether to treat CAP in the community, admit to a general ward, or escalate to ICU.
2. Prognostic Guidance: Informs discussions with patients and families about expected outcomes.
3. Antibiotic Therapy: Supports decisions on empirical antibiotic choice, with higher scores often warranting broader-spectrum agents.
4. Monitoring: Identifies patients needing close observation or early intervention (e.g., for sepsis or respiratory failure).

Scoring Example

• A 70-year-old patient (1 point) with CAP presents with:

   

  • Confusion (1 point)
  • Urea 8 mmol/L (1 point)
  • Respiratory rate 32 breaths/min (1 point)
  • Systolic BP 100 mmHg (0 points)
• Total CURB-65 score = 1 + 1 + 1 + 1 + 0 = 4
• Interpretation: High risk, likely requiring ICU admission and aggressive treatment.

Advantages

• Simplicity: Uses only five variables, easily assessed at the bedside or with basic labs.
• Validated: Strong predictive accuracy for 30-day mortality across diverse populations.
• Rapid: Can be calculated quickly in emergency settings.
• Cost-Effective: Requires minimal testing (urea may be omitted in simplified CRB-65 for resource-limited settings).

Limitations

• Adult Focus: Validated for adults; pediatric pneumonia requires different tools (e.g., Pediatric Respiratory Severity Score).
• Limited Scope: Focuses on mortality risk, not other outcomes like length of stay or complications.
• Lab Dependency: Urea measurement may not be immediately available in primary care, though CRB-65 (omitting urea) is an alternative.
• Comorbidities: Does not account for chronic conditions (e.g., COPD, diabetes) or immunocompromise, which may influence severity.
• Static Assessment: Based on presentation; does not reflect response to treatment or clinical changes.

Implementation

• Data Collection: Ensure accurate assessment of confusion (use standardized tools like AMTS if possible), vital signs, and lab results (urea).
• Calculation: Assign 1 point per criterion met; sum for total score. Online calculators or mobile apps can assist.
• Interpretation: Use score alongside clinical judgment, considering comorbidities, social factors (e.g., home support), and local guidelines.
• Training: Educate staff on consistent measurement (e.g., respiratory rate over 1 minute) to reduce variability.

Comparison with Other Tools

• PSI/PORT Score: More comprehensive (20 variables) for CAP risk stratification but more complex and time-consuming.
• CRB-65: Simplified version omitting urea, useful in primary care or when labs are unavailable.
• APACHE II/SAPS II: ICU-specific, broader severity scores not tailored to CAP.
• SMART-COP: Predicts need for ICU-level care in CAP but requires more data (e.g., albumin, pH).

CURB-65 is preferred for its balance of simplicity and prognostic utility in CAP.

Relevance to Specific Settings

• Emergency Department: Core tool for rapid CAP triage and disposition decisions.
• Primary Care: Guides referral to hospital for moderate/high-risk patients; CRB-65 often used if urea unavailable.
• Hospital Wards: Assists in escalating care for deteriorating patients.
• ICUs: Supports decisions on invasive ventilation or vasopressors for high-risk cases.
• Pediatric/Neonatal Settings: Not applicable; use age-specific tools.

Conclusion

The CURB-65 score is a practical, validated tool for assessing community-acquired pneumonia severity in adults. Its five-criterion framework enables rapid risk stratification, guiding treatment settings and prognostic discussions. Medical professionals should integrate CURB-65 with clinical judgment, local guidelines, and patient-specific factors to optimize CAP management. Its simplicity and effectiveness make it a cornerstone of emergency and hospital care, though it requires careful application to account for its limitations.

For detailed guidelines, scoring calculators, or integration with CAP protocols, consult resources like the British Thoracic Society, American Thoracic Society, or local infectious disease guidelines.